← Leaderboards
Madhuri Wadehra
University Of California Los Angeles
$1,352,273
Attributed
$2,331,866
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $319.6K · FY2009–20$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$2,331,866 · 3
By mechanism
R01$1,568,991 · 1
R21$762,875 · 2
Top collaborators
- Tove Olafsen5 shared
- Khalid A Mohamedali2 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Harvey R. Herschman$16,718,124
- Sanjiv S Gambhir$44,452,033
- Simon R Cherry$33,926,952
- Scott Dixon$7,011,429
- David Stout$1,270,301
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsEvaluationMembrane ProteinsOvarianToxic EffectTumor BurdenIn VitroMalignant NeoplasmsNormal Tissue MorphologyEndometrialRecombinant AntibodyRecombinantsIgg1TumorAnimalsEpithelialIn VivoMalignant Breast NeoplasmApoptosisEngineeringAntibodiesDrug KineticsCancer TherapyHalf-Life
Grant awards (9)
Targeting EMP2 for the treatment of triple negative breast cancer with novel anti-EMP2 Granzyme B immunoconjugates$171,825
R21 · FY2020 · CA · contact PI
Targeting EMP2 for the treatment of triple negative breast cancer with novel anti-EMP2 Granzyme B immunoconjugates$218,370
R21 · FY2019 · CA · contact PI
Using EMP2 for Image Guided Drug Delivery for Breast Cancer$319,550
R01 · FY2016 · CA · contact PI
Using EMP2 for Image Guided Drug Delivery for Breast Cancer$319,550
R01 · FY2015 · CA · contact PI
Using EMP2 for Image Guided Drug Delivery for Breast Cancer$309,964
R01 · FY2014 · CA · contact PI
Using EMP2 for Image Guided Drug Delivery for Breast Cancer$300,377
R01 · FY2013 · CA · contact PI
Using EMP2 for Image Guided Drug Delivery for Breast Cancer$319,550
R01 · FY2012 · CA · contact PI
Targeting EMP2 in Endometrial Cancer$169,400
R21 · FY2010 · CA · contact PI
Targeting EMP2 in Endometrial Cancer$203,280
R21 · FY2009 · CA · contact PI